Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma

Fig. 1

Study flowchart and methodology. A Flow chart of the study population. B Pipeline to train, validate and test the gradient boosting machine. ICC, Intrahepatic cholangiocarcinoma; FAHNJMU, First Affiliated Hospital of Nanjing Medical University; SEER, Surveillance, Epidemiology, and End Results; AJCC, American Joint Committee on Cancer

Back to article page